![](/img/cover-not-exists.png)
A Phase I/II Study of the Janus Kinase (JAK)1 and 2 Inhibitor Ruxolitinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Pemmaraju, Naveen, Kantarjian, Hagop, Kadia, Tapan, Cortes, Jorge, Borthakur, Gautam, Newberry, Kate, Garcia-Manero, Guillermo, Ravandi, Farhad, Jabbour, Elias, Dellasala, Sara, Pierce, Sherry, VerstoVolume:
15
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2014.08.003
Date:
March, 2015
File:
PDF, 328 KB
english, 2015